Business Description
Medico Remedies Ltd
ISIN : INE630Y01024
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | 0.8 | |||||
Interest Coverage | 14.25 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 8.05 | |||||
Beneish M-Score | -1.76 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.1 | |||||
3-Year EBITDA Growth Rate | 42.4 | |||||
3-Year EPS without NRI Growth Rate | 27.9 | |||||
3-Year Book Growth Rate | 18.1 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.01 | |||||
9-Day RSI | 44.58 | |||||
14-Day RSI | 46.18 | |||||
6-1 Month Momentum % | 13.89 | |||||
12-1 Month Momentum % | -47.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.8 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 52.99 | |||||
Days Sales Outstanding | 136.81 | |||||
Days Payable | 111.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.19 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 19.12 | |||||
Operating Margin % | 6.91 | |||||
Net Margin % | 5.5 | |||||
FCF Margin % | 0.15 | |||||
ROE % | 14.81 | |||||
ROA % | 7.74 | |||||
ROIC % | 11.74 | |||||
ROC (Joel Greenblatt) % | 20.11 | |||||
ROCE % | 21.31 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 52.73 | |||||
PE Ratio without NRI | 52.73 | |||||
Shiller PE Ratio | 119.32 | |||||
Price-to-Owner-Earnings | 162.93 | |||||
PEG Ratio | 1.41 | |||||
PS Ratio | 2.9 | |||||
PB Ratio | 7.25 | |||||
Price-to-Tangible-Book | 7.26 | |||||
Price-to-Free-Cash-Flow | 1940.4 | |||||
Price-to-Operating-Cash-Flow | 150.19 | |||||
EV-to-EBIT | 36.52 | |||||
EV-to-EBITDA | 28.95 | |||||
EV-to-Revenue | 2.95 | |||||
EV-to-FCF | 2125.41 | |||||
Price-to-DCF (Earnings Based) | 2.03 | |||||
Price-to-DCF (FCF Based) | 194.04 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.94 | |||||
Price-to-Graham-Number | 4.13 | |||||
Price-to-Net-Current-Asset-Value | 12.01 | |||||
Earnings Yield (Greenblatt) % | 2.74 | |||||
FCF Yield % | 0.05 | |||||
Forward Rate of Return (Yacktman) % | 18.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medico Remedies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 1,396.321 | ||
EPS (TTM) (₹) | 0.92 | ||
Beta | 0.66 | ||
Volatility % | 60.45 | ||
14-Day RSI | 46.18 | ||
14-Day ATR (₹) | 2.983158 | ||
20-Day SMA (₹) | 48.959 | ||
12-1 Month Momentum % | -47.14 | ||
52-Week Range (₹) | 35 - 91.97 | ||
Shares Outstanding (Mil) | 82.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medico Remedies Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medico Remedies Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Medico Remedies Ltd Frequently Asked Questions
What is Medico Remedies Ltd(BOM:540937)'s stock price today?
When is next earnings date of Medico Remedies Ltd(BOM:540937)?
Does Medico Remedies Ltd(BOM:540937) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |